VYGR Insider Trading Activity and SEC Form 4 Filings
VYGR insider trading summary
Over the past 12 months, insiders at Voyager Therapeutics, Inc. (VYGR) reported 4 sales worth $109K by 3 insiders and no open-market purchases on SEC Form 4. Net insider selling was $109K.
Latest VYGR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 2, 2026 | Alfred Sandrock | President and CEO | Sell | $45K (11,511 @ $3.87) |
| Feb 18, 2026 | Alfred Sandrock | President and CEO | Sell | $40K (11,732 @ $3.41) |
| Feb 18, 2026 | Robin Swartz | COO & Cbo | Sell | $13K (3,882 @ $3.44) |
| Feb 18, 2026 | Todd Alfred Carter | Chief Scientific Officer | Sell | $11K (3,301 @ $3.44) |
| Oct 3, 2025 | Nathan D. Jorgensen | Chief Financial Officer | Sell | $37K (7,666 @ $4.78) |
| Aug 18, 2025 | Toby Ferguson | Chief Medical Officer | Sell | $71K (19,000 @ $3.73) |
| Apr 2, 2025 | Alfred Sandrock | President and CEO | Sell | $37K (10,885 @ $3.43) |
| Apr 2, 2025 | Toby Ferguson | Chief Medical Officer | Sell | $35K (10,086 @ $3.43) |
| Feb 20, 2025 | Robin Swartz | COO & Cbo | Sell | $17K (3,894 @ $4.25) |
| Feb 20, 2025 | Alfred Sandrock | President and CEO | Sell | $50K (11,702 @ $4.24) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.